Plasma matrix metalloproteinases and tissue inhibitors of metalloproteinases explored in relation to the severity and progression of diabetic retinopathy in patients with type 1 diabetes: baseline and prospective analyses
Aims To explore whether circulating matrix metalloproteinase-2 (MMP-2), MMP-9, MMP-9/neutrophil gelatinase-associated lipocalin, MMP-9/tissue inhibitor of metalloproteinase-1 (TIMP-1), MMP-14, TIMP-2 and TIMP-3 were associated with the severity and progression of diabetic retinopathy (DR) in patient...
Saved in:
Main Authors: | Sven Hector, Hans Olav Thulesius, Mona Landin-Olsson, Magnus Hillman, Eva Olga Melin, Maria Thunander |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-08-01
|
Series: | BMJ Open Ophthalmology |
Online Access: | https://bmjophth.bmj.com/content/9/1/e001583.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus
by: Lucia Saucedo, et al.
Published: (2021-01-01) -
Role of Matrix Metalloproteinase-8 in Atherosclerosis
by: Sébastien Lenglet, et al.
Published: (2013-01-01) -
Matrix Metalloproteinases in patients with Multiple Sclerosis.
by: Rebeca A. Fernández Carriera, et al.
Published: (2007-05-01) -
Increased Matrix Metalloproteinase-2 and Matrix Metalloproteinase-3 Concentrations in Corneal Epithelium of Patients with Recurrent Corneal Erosions
by: Katarzyna Jadczyk-Sorek, et al.
Published: (2022-01-01) -
The Effect of Autologous Platelet-Rich Gel on the Dynamic Changes of the Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 Expression in the Diabetic Chronic Refractory Cutaneous Ulcers
by: Lan Li, et al.
Published: (2015-01-01)